<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Vet Sci</journal-id><journal-id journal-id-type="iso-abbrev">Vet Sci</journal-id><journal-id journal-id-type="publisher-id">vetsci</journal-id><journal-title-group><journal-title>Veterinary Sciences</journal-title></journal-title-group><issn pub-type="epub">2306-7381</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40005861</article-id><article-id pub-id-type="pmc">PMC11861430</article-id><article-id pub-id-type="doi">10.3390/vetsci12020101</article-id><article-id pub-id-type="publisher-id">vetsci-12-00101</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Development and Efficacy Evaluation of a Novel Nanoparticle-Based Hemagglutination Inhibition Assay for Serological Studies of Porcine Epidemic Diarrhea Virus</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Liang</surname><given-names>Fengyan</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><xref rid="af1-vetsci-12-00101" ref-type="aff">1</xref><xref rid="fn1-vetsci-12-00101" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Qiao</surname><given-names>Wenyue</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><xref rid="af1-vetsci-12-00101" ref-type="aff">1</xref><xref rid="fn1-vetsci-12-00101" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Mengjia</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><xref rid="af2-vetsci-12-00101" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Hu</surname><given-names>Zhangtiantian</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><xref rid="af1-vetsci-12-00101" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Shan</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><xref rid="af1-vetsci-12-00101" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Yan</surname><given-names>Qigui</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><xref rid="af1-vetsci-12-00101" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-7114-762X</contrib-id><name><surname>Li</surname><given-names>Wentao</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><xref rid="af2-vetsci-12-00101" ref-type="aff">2</xref><xref rid="c1-vetsci-12-00101" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Lang</surname><given-names>Yifei</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><xref rid="af1-vetsci-12-00101" ref-type="aff">1</xref><xref rid="c1-vetsci-12-00101" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Maes</surname><given-names>Dominiek</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-vetsci-12-00101"><label>1</label>College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611130, China; <email>fdzdyyy@163.com</email> (F.L.); </aff><aff id="af2-vetsci-12-00101"><label>2</label>National Key Laboratory of Agricultural Microbiology, Hubei Hongshan Laboratory, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China</aff><author-notes><corresp id="c1-vetsci-12-00101"><label>*</label>Correspondence: <email>wentao@mail.hzau.edu.cn</email> (W.L.); <email>y_langviro@163.com</email> (Y.L.)</corresp><fn id="fn1-vetsci-12-00101"><label>&#x02020;</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>01</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>12</volume><issue>2</issue><elocation-id>101</elocation-id><history><date date-type="received"><day>31</day><month>12</month><year>2024</year></date><date date-type="rev-recd"><day>24</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>27</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract abstract-type="plain-language-summary"><title>Simple Summary</title><p>Porcine epidemic diarrhea virus (PEDV) is a highly contagious enteric pathogen and has caused severe economic losses to the global swine industry. In view of this, the development of rapid and accurate serological diagnostic methods is essential for the monitoring of antibody levels after PEDV infection or vaccine development. In this study, a safe and easy-to-operate method for the detection of PEDV neutralizing antibodies was constructed. The PEDV S1<sup>0A</sup>-Spy recombinant protein containing a sialic acid-binding motif was expressed and then presented onto SpyCatcher-mi3 nanoparticles to establish a novel virus-free hemagglutination inhibition (HI) assay. The HI assay showed good specificity and sensitivity, and the obtained HI titers correlated well with the corresponding virus neutralizing titers. It can be used as an important tool for the monitoring of PEDV neutralizing antibodies and a new way for the serological diagnosis of PEDV.</p></abstract><abstract><title>Abstract</title><p>Porcine epidemic diarrhea virus (PEDV) is a major pathogen that causes serious economic losses to the swine industry. To aid PEDV clinical diagnosis and vaccine development, sensitive and precise serological methods are demanded for rapid detection of (neutralizing) antibodies. Aiming for the development of a novel virus-free hemagglutination inhibition (HI) assay, the N-terminal region of the PEDV S1 subunit, encompassing the sialic acid-binding motif, was first expressed as an Fc-fusion protein with a C-terminal Spy Tag (S1<sup>0A</sup>-Spy). The S1<sup>0A</sup>-Spy protein was then presented on SpyCatcher-mi3 nanoparticles, forming virus-like particles designated S1<sup>0A</sup>-NPs. Electron microscopy and dynamic light scattering analysis confirmed its topology, and the hemagglutination assay showed that S1<sup>0A</sup>-NPs can efficiently agglutinate red blood cells. The HI assay based on S1<sup>0A</sup>-NPs was then validated with PEDV-positive and -negative samples. The results showed that the HI assay had high specificity for the detection of PEDV antibodies. Next, a total of 253 clinical serum samples were subjected to the HI testing along with virus neutralization (VN) assay. The area under the receiver operating characteristic curve with VN was 0.959, and the <italic toggle="yes">kappa</italic> value was 0.759. Statistical analysis of the results indicated that the HI titers of the samples tested exhibited high consistency with the VN titers. Taken together, a novel virus-free HI assay based on the multivalent display of a chimeric PEDV spike protein upon self-assembling nanoparticles was established, providing a new approach for PEDV serological diagnosis.</p></abstract><kwd-group><kwd>porcine epidemic diarrhea virus</kwd><kwd>serology</kwd><kwd>S1<sup>0A</sup> protein</kwd><kwd>nanoparticle</kwd><kwd>hemagglutination inhibition assay</kwd></kwd-group><funding-group><award-group><funding-source>National Natural Science Foundation of China</funding-source><award-id>32473007</award-id></award-group><award-group><funding-source>Joint Funds of Science Technology and Education of Sichuan Province</funding-source><award-id>2024NSFSC2063</award-id></award-group><funding-statement>This work was supported by the National Natural Science Foundation of China (32473007) and the Joint Funds of Science Technology and Education of Sichuan Province (2024NSFSC2063).</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-vetsci-12-00101"><title>1. Introduction</title><p>Porcine epidemic diarrhea (PED), a swine epidemic disease caused by porcine epidemic diarrhea virus (PEDV), is characterized by severe watery diarrhea, vomiting, dehydration and high mortality in piglets [<xref rid="B1-vetsci-12-00101" ref-type="bibr">1</xref>]. PEDV is an enveloped virus with a single-stranded, positive-sense RNA genome approximately 28 kb in length. It contains seven open reading frames, which encode four structural proteins, namely the spike protein (S), envelope protein (E), membrane protein (M) and nucleocapsid protein (N) [<xref rid="B2-vetsci-12-00101" ref-type="bibr">2</xref>,<xref rid="B3-vetsci-12-00101" ref-type="bibr">3</xref>]. S is the main surface glycoprotein budded on the virus membrane of PEDV, which can be further divided into S1 and S2 subunits. The S1 subunit contains major neutralizing epitopes and mediates the binding of virus to specific host cell receptors and induces neutralizing antibodies in natural hosts, while the S2 subunit mediates the fusion of the virus and host cell membrane post virus attachment [<xref rid="B4-vetsci-12-00101" ref-type="bibr">4</xref>,<xref rid="B5-vetsci-12-00101" ref-type="bibr">5</xref>,<xref rid="B6-vetsci-12-00101" ref-type="bibr">6</xref>].</p><p>PEDV strains can be classified into two genotypes by phylogenetic analyses based on the S coding sequence: Genotype I (GI) and Genotype II (GII) [<xref rid="B7-vetsci-12-00101" ref-type="bibr">7</xref>]. The GI CV777 strain was first isolated in 1978 and epidemic in Europe [<xref rid="B8-vetsci-12-00101" ref-type="bibr">8</xref>]. In 2010, highly virulent GII PEDV strains emerged in China, causing severe PEDV outbreaks that subsequently spread across the country, resulting in a mortality rate of up to 100% in piglets and causing serious economic losses to the swine breeding industry [<xref rid="B9-vetsci-12-00101" ref-type="bibr">9</xref>,<xref rid="B10-vetsci-12-00101" ref-type="bibr">10</xref>]. Highly pathogenic PEDV was first detected in the United States in April 2013 and rapidly spread to 31 states, as well as Mexico and Canada [<xref rid="B11-vetsci-12-00101" ref-type="bibr">11</xref>]. PEDV GII quickly became the dominant strain worldwide and currently circulates in swine farms in Asia, Europe and North America, causing enormous economic losses to the swine industry and posing a potential threat to public health [<xref rid="B12-vetsci-12-00101" ref-type="bibr">12</xref>]. It has been shown that variations in the S gene, the major virulence factor, can alter the pathogenicity of PEDV, which enlarged the challenge of PEDV prevention and control in China [<xref rid="B13-vetsci-12-00101" ref-type="bibr">13</xref>,<xref rid="B14-vetsci-12-00101" ref-type="bibr">14</xref>]. In PEDV-infected pigs, the retention time of S protein antibodies in serum was longer than that of N protein antibodies due to the robust antigenicity of the S protein [<xref rid="B15-vetsci-12-00101" ref-type="bibr">15</xref>]. Furthermore, the S1 region has been shown to be a suitable target for determining genetic relationships among PEDV isolates and for developing differential diagnostic assays and effective vaccines [<xref rid="B16-vetsci-12-00101" ref-type="bibr">16</xref>,<xref rid="B17-vetsci-12-00101" ref-type="bibr">17</xref>]. Therefore, the S protein is the ideal antigen for vaccine development and the establishment of diagnostic methods.</p><p>The S1 subunit is comprised of four core domains, S1<sup>A</sup> to S1<sup>D</sup>, whereas many alphacoronaviruses, including PEDV, contain an additional N-terminal domain, S1<sup>0</sup> [<xref rid="B18-vetsci-12-00101" ref-type="bibr">18</xref>,<xref rid="B19-vetsci-12-00101" ref-type="bibr">19</xref>]. The S1<sup>B</sup> domain is known to function as a receptor-binding domain for a variety of coronaviruses, such as transmissible gastroenteritis virus (TGEV) [<xref rid="B20-vetsci-12-00101" ref-type="bibr">20</xref>], middle east respiratory syndrome coronavirus (MERS-CoV) [<xref rid="B21-vetsci-12-00101" ref-type="bibr">21</xref>,<xref rid="B22-vetsci-12-00101" ref-type="bibr">22</xref>] and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [<xref rid="B23-vetsci-12-00101" ref-type="bibr">23</xref>]. In addition, certain PEDV strains have sialic acid (SA)-binding activity and hemagglutination activity, which were mapped to the amino-terminal 246 residues, constituted mostly by S1<sup>0</sup> of the PEDV S1 subunit [<xref rid="B6-vetsci-12-00101" ref-type="bibr">6</xref>]. Li et al. identified six neutralizing or non-neutralizing epitopes in the S1 subunit of the PEDV spike protein, which further confirmed that the neutralizing epitopes may be mainly located in the region with SA-binding activity (amino acids 19-246, mostly S1<sup>0</sup>) or the deduced proteinaceous receptor-binding domain (S1<sup>B</sup>) [<xref rid="B24-vetsci-12-00101" ref-type="bibr">24</xref>].</p><p>Taking into consideration the huge threat that PEDV poses to the swine breeding industry, it is of utmost importance to establish rapid and accurate PEDV detection methods to effectively block PEDV transmission and prevent major outbreaks. Diagnostic methods for PEDV are currently divided into two categories: etiological and serological diagnostic methods. Etiological diagnostic methods are mainly based on the detection of viral nucleic acids or proteins, such as by polymerase chain reaction (PCR). Serological diagnostic methods investigate for antibodies produced by the host immune system post virus infection, such as by the indirect immunofluorescence test (IFA), virus neutralization test (VN) and enzyme-linked immunosorbent assay (ELISA) [<xref rid="B25-vetsci-12-00101" ref-type="bibr">25</xref>,<xref rid="B26-vetsci-12-00101" ref-type="bibr">26</xref>]. Serological assays determine previous pathogen exposure by identifying the presence of antibodies. Ferrara et al. used an enzyme-linked immunosorbent assay (ELISA) method to explore the transmission of porcine coronaviruses (including PEDV) and porcine reproductive and respiratory syndrome virus in southern Italy, and the results showed that PEDV was the most common coronavirus circulating in pigs in the region [<xref rid="B27-vetsci-12-00101" ref-type="bibr">27</xref>]. In the first seroepidemiological study of PEDV in Mexico, it was reported that 61.66% of the serum samples were positive, showing that PEDV is still circulating in the main pig-producing states in Mexico [<xref rid="B28-vetsci-12-00101" ref-type="bibr">28</xref>]. Serology studies of PEDV can effectively reveal the epidemic status of PEDV in certain areas, which is of great significance for PED prevention and control. The outcome of serological methods can monitor the immune status of the population, which is important for determining the infection status of a specific herd or evaluating the protecting effects post vaccination. One major hurdle for PEDV serological methods is the assessment of neutralizing antibodies elicited by PEDV infection. The VN assay is generally recognized as the &#x0201c;golden standard&#x0201d;, but its application requires culturing of contagious PEDV contained within biosafety laboratories. Therefore, the development of safe, easily operatable methods with results congruent to VN is genuinely necessitated for PEDV serology.</p><p>As a classic technique in the diagnosis of infectious pathogens, the hemagglutination assay (HA) is operatable and economically efficient and has been widely used in the qualitative or quantitative analysis of viruses with agglutinating ability, such as influenza virus [<xref rid="B29-vetsci-12-00101" ref-type="bibr">29</xref>]. The derived hemagglutination inhibition (HI) assay was henceforth developed to detect antibodies that block the virus&#x02013;erythrocyte interaction [<xref rid="B30-vetsci-12-00101" ref-type="bibr">30</xref>]. Due to its high sensitivity and specificity, the HI assay has now become one of the classic tools of global influenza surveillance, and VN and HI assays are generally recognized as the &#x0201c;gold standards&#x0201d; for detecting influenza virus-neutralizing antibodies [<xref rid="B31-vetsci-12-00101" ref-type="bibr">31</xref>]. Of note, to avoid culturing of virus particles, designations of de novo HA and HI assays through presenting recombinant viral proteins on platforms such as magnetic beads or nanoparticles have been applied in numerous studies [<xref rid="B32-vetsci-12-00101" ref-type="bibr">32</xref>,<xref rid="B33-vetsci-12-00101" ref-type="bibr">33</xref>].</p><p>In the present study, we developed a novel HI assay for the detection of PEDV antibody levels through a multimeric exhibition of the chimeric PEDV S protein on self-assembling mi3 nanoparticles. Our data show that the results obtained with the newly developed HI assay are highly compatible with the VN results, which underscores the potential of large-scale application of HI assay in monitoring PEDV-specific antibody response for seroprevalence analyses or the evaluation of vaccine compliance.</p></sec><sec id="sec2-vetsci-12-00101"><title>2. Material and Methods</title><sec id="sec2dot1-vetsci-12-00101"><title>2.1. Viruses, Cell Lines and Clinical Samples</title><p>The PEDV/SC/2020 strain was isolated and preserved by the College of Veterinary Medicine, Sichuan Agricultural University. Human embryonic kidney 293 cells (HEK-293T) and African green monkey kidney epithelial (Vero) cells, preserved by the College of Veterinary Medicine, Sichuan Agricultural University, were cultured in Dulbecco&#x02019;s modified Eagle medium (DMEM; Gibco, Grand Island, NY, USA) supplemented with 10% (<italic toggle="yes">w</italic>/<italic toggle="yes">v</italic>) fetal bovine serum (FBS) (ExCell Bio, Suzhou, China), penicillin (100 IU/mL) and streptomycin (100 &#x003bc;g/mL). PEDV-negative sera were collected from specific-pathogen-free (SPF) pigs, while PEDV-positive sera were collected from recovered pigs post PEDV infection from farms and validated by virus neutralization tests in our laboratory. From 2020 to 2022, 253 clinical serum samples were collected across four provinces in China (Sichuan, Fujian, Zhejiang and Chongqing) from pigs of different ages, including nursery pigs, fattening pigs, milking sows, breeding boars, gilts and piglets and stored at &#x02212;80 &#x000b0;C in our laboratory.</p></sec><sec id="sec2dot2-vetsci-12-00101"><title>2.2. Construct Design, Protein Expression and Purification</title><p>The PEDV S1<sup>0A</sup> domain (amino acids 19 to 504) encoding was cloned from viral cDNA into a pcDNA-3.1 expression plasmid. Briefly, the S1<sup>0A</sup> gene was cloned in frame with a sequence encoding a CD5 N-terminal signal peptide and the Fc domain of mouse IgG2a (mFc) in the C-terminal for protein purification. In order to produce the S1<sup>0A</sup> protein (S1<sup>0A</sup>-Spy) to be conjugated to SpyCatcher, the construct of S1<sup>0A</sup> was designed as described above, with the addition of a sequence encoding a Spy tag (AHIVMVDAYKPTK) at the C-terminal of the construct, which produces a fusion protein, S1<sup>0A</sup>-Fc-Spy. The constructed plasmid was verified by sequencing. The S1<sup>0A</sup>-Spy protein was expressed in HEK-293T cells. In detail, Lipo293<sup>TM</sup> (Beyotime, Shanghai, China) transfection reagent was used to transfect pcDNA3.1-S1<sup>0A</sup>-Fc-Spy plasmid into HEK-239T cells. At 6 to 7 days post-transfection, cell supernatants containing the soluble S1<sup>0A</sup> protein were harvested, and the protein was purified by protein A-affinity chromatography (Sino Biological, China) according to the manufacturer&#x02019;s instructions. The purified protein was quantified by NanoDrop spectrophotometry, checked by Western blot and stored at &#x02212;80 &#x000b0;C until further usage.</p></sec><sec id="sec2dot3-vetsci-12-00101"><title>2.3. Construction, Expression and Purification of SpyCatcher-mi3 Nanoparticles</title><p>The gene encoding the trimeric aldolase (mi3) derived from the hyperthermophilic bacterium <italic toggle="yes">Thermotoga maritima</italic> and SpyCatcher sequence from the CnaB2 domain of the FbaB adhesion protein from the common Streptococcus pyogenes (GenBank accession no.MH425515) was synthesized by Sangon (Biotech, Shanghai, China). The gene sequence was codon-optimized for optimized <italic toggle="yes">E. coli</italic> expression and then cloned into pET28a expression plasmid. In addition, a sequence encoding the Strep-tag at the C-terminal for protein purification was introduced into the gene sequence. The pET28a expression plasmid was transformed into <italic toggle="yes">Escherichia coli</italic> strain BL21 (Vazyme, Nanjing, China). A single colony was picked into a 10 mL starter culture of LB medium containing 100 &#x003bc;g/mL ampicillin and incubated for 16 h at 37 &#x000b0;C with shaking at 200 rpm. Then, the culture was expanded in LB liquid medium containing 100 &#x003bc;g/mL ampicillin at 1% inoculum. At <italic toggle="yes">A<sub>600</sub></italic> 0.8, cultures were induced with 0.5 mM IPTG (isopropyl &#x003b2;-D-thiogalactoside) and grown for 16&#x02212;20 h with shaking at 200 rpm at 22 &#x000b0;C. After induction, the bacteria were collected by centrifugation and sonicated on ice. Then, the lysis mixture was spun down at 14,000&#x000d7; <italic toggle="yes">g</italic> for 30 min at 4 &#x000b0;C. After collecting the supernatant, SpyCatcher-mi3 nanoparticle (NP) was purified using Strep-Tactin Sepharose beads according to the manufacturer&#x02019;s instructions (IBA, Germany). Purified NPs were stored at &#x02212;80 &#x000b0;C until further use.</p></sec><sec id="sec2dot4-vetsci-12-00101"><title>2.4. Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) and Western Blotting (WB)</title><p>Purified proteins as described above were mixed with 5 &#x000d7; SDS-PAGE loading buffer (with DTT) (Solarbio, China) and boiled at 95 &#x000b0;C for 10 min. The proteins were separated on SDS-PAGE gel under reduction conditions and stained with Coomassie bright blue. In addition, the S1<sup>0A</sup>-Spy protein was loaded on an SDS-PAGE gel and subsequently electroblotted onto a polyvinylidene (PVDF) difluoride membrane. The membrane was then blocked with 5% powdered skim milk with 0.05% Tween-20 (TBST) at room temperature for 2 h and then reacted directly with the goat anti-mouse IgG HRP-conjugated (ABclonal, Wuhan, China) secondary antibody at a 1:1000 dilution for 1 h at room temperature. Finally, the protein was visualized using Pierce ECL Western blotting substrate (Thermo Fisher, Waltham, MA, USA) according to the manufacturer&#x02019;s protocol.</p></sec><sec id="sec2dot5-vetsci-12-00101"><title>2.5. Transmission Electron Microscopy (TEM)</title><p>S1<sup>0A</sup>-Spy was conjugated at 25 &#x000b0;C for 36 h with SpyCatcher-mi3 nanoparticles (NP: S1<sup>0A</sup>, molar ratio 1:1.5) in reaction buffer (25 mM Tris-HCl [pH 8.5], 150 mM NaCl [pH 8.5]). Subsequently, 100 &#x003bc;L solution was transferred into a 1.5 mL EP tube and sent to Servicebio (Wuhan, China) for TEM observation. The sample (0.2 mg/mL) was applied to freshly glow-discharged carbon 400 mesh copper grids for 2 min and blotted with filter paper. Then, the nanoparticles were stained with 8 &#x003bc;L 1% phosphotungstic acid (PTA) for 1 min, the staining solution was removed by filter paper and the structure of the nanoparticles was observed by transmission electron microscope after drying at room temperature.</p></sec><sec id="sec2dot6-vetsci-12-00101"><title>2.6. Dynamic Light Scattering (DLS)</title><p>The particle size distribution of the nanoparticles in this study was measured by DLS using a Zetasizer (Malvern Panalytical, Malvern, UK). The samples were diluted 0.1% (<italic toggle="yes">w/v</italic>) with deionized water with a pH = 7.0; a total of 1 mL of the sample was absorbed and injected into the colorimetric dish followed by triplicate analysis using this apparatus with an angle of 173&#x000b0;. The temperature was 25 &#x000b0;C and equilibration time was set to 120 s. The data were analyzed using the software provided by Malvern Instruments. Particle dH was obtained from the peak of intensity (%) vs. diameter (nm) curve (PSDi).</p></sec><sec id="sec2dot7-vetsci-12-00101"><title>2.7. Preparation of PEDV S1<sup>0A</sup> Protein Mouse Polyantiserum</title><p>The purified PEDV S1<sup>0A</sup> protein was used as an immunogen, and three six-week-old female BALB/c mice (Dossy, Chengdu, China) were immunized by subcutaneous injection at a dose of 100 &#x003bc;g per mouse. Freund&#x02019;s complete adjuvant (BBI, Shanghai, China) was used for primary immunization, and Freund&#x02019;s incomplete adjuvant (BBI, Shanghai, China) was used for secondary immunization. Serum samples were collected 14 days after the secondary immunization. All the animal use protocols commissioned in this study were reviewed and approved by the Animal Ethics Committee of Sichuan Agricultural University.</p></sec><sec id="sec2dot8-vetsci-12-00101"><title>2.8. Hemagglutination and Hemagglutination Inhibition Assays with S1<sup>0A</sup>-Conjugated SpyCatcher-mi3 Nanoparticles</title><p>S1<sup>0A</sup> was conjugated with SpyCatcher-mi3 nanoparticles to form S1<sup>0A</sup>-NPs, as described above. Subsequently, S1<sup>0A</sup>-NPs were then 2-fold serially diluted and mixed 1:1 with human erythrocytes (0.5% in PBS). Hemagglutination was assessed after incubation on ice for 2 h, and the hemagglutinating units (HAUs) were calculated for each S1<sup>0A</sup>-NP.</p><p>To study the HI ability of serum samples, the serum samples were first mixed with 1% human red blood cell (Immocell, Xiamen, China) suspension at a 1:1 ratio, placed at 4 &#x000b0;C for adsorption overnight, centrifuged to collect the supernatant, and then the serum was inactivated at 56 &#x000b0;C for 30 min. The treated serum samples were then 2-fold serially diluted and mixed 1:1 with PBS containing 4 HAUs of S1<sup>0A</sup>-NPs. The mixtures were incubated at room temperature for 30 min and then mixed 1:1 with human erythrocytes (0.5% in PBS). Hemagglutination inhibition was recorded after 2 h of incubation on ice. The maximum dilution factor of completely inhibiting erythrocyte agglutination was used as the coagulation-inhibiting titer of the serum. Each serum sample was analyzed three times independently, and the average HI titer was used. Serum samples with an HI titer higher than 1:40 were considered to be seropositive based on the collective analysis of PEDV reference serum samples.</p></sec><sec id="sec2dot9-vetsci-12-00101"><title>2.9. Virus Neutralization (VN) Test</title><p>Serum samples were continuously diluted twice with serum-free DMEM, then added to 96-well plates, then added with the equivalent of 200TCID<sub>50</sub> PEDV virus and mixed at 37 &#x000b0;C for 1 h. The serum&#x02013;virus mixture was inoculated onto Vero cells at 37 &#x000b0;C for 2 h, the supernatant was discarded, washed twice with PBS, 200 &#x003bc;L serum-free DMEM (containing 5 &#x003bc;g/mL trypsin) was added and the cytopathic effect (CPE) was observed at each pore for 48&#x02013;72 h. The virus neutralization titer was defined as the reciprocal of the highest serum dilution for absolute suppression of PEDV infection. Each serum sample was analyzed three times independently, and the average VN titer was used.</p></sec><sec id="sec2dot10-vetsci-12-00101"><title>2.10. Comparison Between HI Assay and VN with Clinical Samples</title><p>Clinical serum samples were collected and tested by HI assay and VN test. Results were compared with the VN to assess the performance of HI in terms of relative sensitivity&#x02014;[(true positive/(true positive&#x02009; + &#x02009;false negative)] &#x000d7; 100%&#x02014;and relative specificity&#x02014;[(true negative/(true negative&#x02009; + &#x02009;false positive)]&#x02009; &#x000d7; 100%&#x02014;and to analyze the coincidence rate (Kappa value) between the HI assay and VN. GraphPad Prism software (version 9.0) and IBM SPSS Statistics 27 software were used for the statistical analyses. Cohen&#x02019;s kappa values were determined as a measure of the overall agreement. <italic toggle="yes">p</italic>-values of less than 0.05 were considered statistically significant.</p></sec></sec><sec sec-type="results" id="sec3-vetsci-12-00101"><title>3. Results</title><sec id="sec3dot1-vetsci-12-00101"><title>3.1. Production of S1<sup>0A</sup>-Spy Recombinant Protein and Spycatcher-mi3 Nanoparticles</title><p>In order to produce the S1<sup>0A</sup> protein (S1<sup>0A</sup>-Spy) conjugated with its matching protein SpyCatcher, the Spy Tag sequence was added to the C-terminus of the mFc region (<xref rid="vetsci-12-00101-f001" ref-type="fig">Figure 1</xref>A). This chimeric protein was then produced in mammalian cells (HEK-293T) by transfection and purification. The recombinant protein was then verified by WB and shown to migrate to its expected size, indicating the successful expression and purification of the S1<sup>0A</sup>-Spy protein (<xref rid="vetsci-12-00101-f001" ref-type="fig">Figure 1</xref>B).</p><p>To create a plug-and-display nano scaffold, the coding sequence of the trimeric aldolase (mi3) derived from the hyperthermophilic bacterium <italic toggle="yes">Thermotoga maritima</italic> was synthesized, which can self-assemble into a well-organized 60 mer dodecahedral nanoparticle. To allow multivalent presentation of Spy-tagged PEDV S1<sup>0A</sup>, SpyCatcher was displayed on the nanoparticle surface, and the S1<sup>0A</sup> protein was confirmed to bind SpyCatcher via their Spy Tag (<xref rid="vetsci-12-00101-f001" ref-type="fig">Figure 1</xref>C). The SpyCatcher-mi3 nanoparticles (NPs) with N-terminal strep tags were appended for affinity purification. Successful expression and purification of NPs were confirmed with SDS-PAGE analysis (<xref rid="vetsci-12-00101-f001" ref-type="fig">Figure 1</xref>D).</p></sec><sec id="sec3dot2-vetsci-12-00101"><title>3.2. PEDV S1<sup>0A</sup> Protein Can Be Displayed Successfully on mi3 Nanoparticles</title><p>The purified recombinant protein S1<sup>0A</sup>-Spy and SpyCatcher-mi3 nanoparticles (molar ratio 1:1.5) were incubated at 25 &#x000b0;C for 36 h to achieve full coupling, thus generating S1<sup>0A</sup>-Spy: Spycatter-mi3 (S1<sup>0A</sup>-NPs). As shown in <xref rid="vetsci-12-00101-f002" ref-type="fig">Figure 2</xref>A, SDS-PAGE analysis showed that effective conjugation was achieved between S1<sup>0A</sup>-Spy and SpyCatcher-mi3, with the expected molecular weight migration, which confirmed the occurrence of assembly reaction and high conjugation efficiency. The shape and size of the S1<sup>0A</sup>-NPs were analyzed by transmission electron microscopy (TEM) to explore whether the S1<sup>0A</sup>-NPs were correctly assembled. The results showed that S1<sup>0A</sup>-Spy and SpyCatcher-mi3 were able to assemble to the particle structure of 60 polymers as regular dodecahedrons (<xref rid="vetsci-12-00101-f002" ref-type="fig">Figure 2</xref>B). To further verify the multivalent display of the S1<sup>0A</sup>-Spy protein on the surface of Spycatard-mi3 nanoparticles, the particle size distribution of Spycatard-mi3 nanoparticles and S1<sup>0A</sup>-NPs were determined by dynamic light scattering (DLS) analysis. <xref rid="vetsci-12-00101-f002" ref-type="fig">Figure 2</xref>C,D shows that the mean diameter of mi3 NPs is about 47.44 nm, and that of S1<sup>0A</sup>-NPs is about 90.11 nm, which confirms the occurrence of the conjugation, indicating that the S1<sup>0A</sup>-Spy protein and SpyCatcher-mi3 nanoparticles were correctly coupled through the isopeptic bond.</p></sec><sec id="sec3dot3-vetsci-12-00101"><title>3.3. NP-Based HI Assay Has High Specificity and Is Suitable for Clinical Sample Detection</title><p>We next tested the ability of the SpyCatcher-mi3: S1<sup>0A</sup>-Spy nanoparticles (S1<sup>0A</sup>-NPs) to agglutinate human erythrocytes by using &#x0201c;empty&#x0201d; NPs as a negative control. Strong agglutination of human erythrocytes was indeed observed for NPs displaying S1<sup>0A</sup> (S1<sup>0A</sup>-NPs), with 2048 hemagglutination units (HAUs) at a concentration of 1&#x000b5;M, but not for trimeric &#x0201c;empty&#x0201d; NPs (<xref rid="vetsci-12-00101-f003" ref-type="fig">Figure 3</xref>A). The above results indicate that S1<sup>0A</sup>-NPs display robust hemagglutination ability and indicate that these NPs can be used for serology screening using the HI assay.</p><p>Next, we explored the inhibitory properties of virus neutralization assay-validated porcine serum samples with HI assay by using the S1<sup>0A</sup>-NPs. Based on the results of the HA assay, the hemagglutination titer of S1<sup>0A</sup>-NPs was first determined, and a PBS solution containing 4 HAUs of S1<sup>0A</sup>-NPs was prepared as an antigen. The reference sera were then analyzed for HI ability. As shown in <xref rid="vetsci-12-00101-f003" ref-type="fig">Figure 3</xref>B, PEDV negative samples (<italic toggle="yes">n</italic> = 3) showed no hemagglutination inhibition (HI titer &#x0003c; 40), while the HA activity of S1<sup>0A</sup>-NPs could be inhibited by PEDV-positive serum samples (<italic toggle="yes">n</italic> = 3, neutralization titer of 1:64) with different HI titers (HI titers of 1:80, 1:160 and 1:160, respectively), indicating that the HI based on S1<sup>0A</sup>-NPs is specifically due to the S1<sup>0A</sup>&#x02013;antibody interaction. In addition, polyclonal antibodies targeting PEDV S1<sup>0A</sup> prepared from mice immunized with the PEDV S1<sup>0A</sup> protein were also tested through VN and HI assay, resulting in a neutralization titer of 1:5 and HI titer of 1:160. VN and HI assay showed consistency in the analysis of this serum, which also indicated that antibodies specific to the PEDV S1<sup>0A</sup> protein could contribute to the neutralization process of PEDV. Apparently, the S1<sup>0A</sup>-NP-based HI assay exhibits high specificity for the detection of PEDV antibodies, which is a desirable characteristic for accurately identifying and differentiating PEDV infections.</p></sec><sec id="sec3dot4-vetsci-12-00101"><title>3.4. Application of S1<sup>0A</sup>-NP-Based HI to Clinical Samples</title><p>To further validate the S1<sup>0A</sup>-NP-based HI assay in the application of an analysis of PEDV antibody prevalence in clinical samples, a total of 253 porcine clinal samples were examined with the newly developed HI assay side by side with the VN assay. As shown in <xref rid="vetsci-12-00101-t001" ref-type="table">Table 1</xref> and <xref rid="vetsci-12-00101-f004" ref-type="fig">Figure 4</xref>A, the HI assay detected 54 positive samples and 199 negative samples, while the VN detected 36 positive samples and 217 negative samples (titers detailed in <xref rid="app1-vetsci-12-00101" ref-type="app">Supplementary Table S1</xref>). Notably, no HI-negative sample was defined as VN-positive, indicating that the HI analysis was accurate and sensitive. The coincidence rate (<italic toggle="yes">Kappa</italic> value) between the results of the two methods analyzed by SPSS Statistics 27 software was 0.759, which indicates that the two methods have good consistency (<italic toggle="yes">Kappa</italic> &#x02265; 0.75). The receiver operating characteristic (ROC) analysis was further utilized to analyze the test results, and the results indicate that the HI assay and VN assay are well-correlated, with the area under the ROC curve (AUC) being 0.959 (<xref rid="vetsci-12-00101-f004" ref-type="fig">Figure 4</xref>B). The relative sensitivity of the HI assay was 100.00%, and the relative specificity of the HI assay was 91.71%, which showed high specificity and sensitivity compared with the VN assay.</p></sec></sec><sec sec-type="discussion" id="sec4-vetsci-12-00101"><title>4. Discussion</title><p>Since 2010, a large-scale PEDV outbreak occurred in China, and highly virulent Genotype II (GII) PEDV variants emerged in various regions, resulting in mortality up to 100% in piglets [<xref rid="B9-vetsci-12-00101" ref-type="bibr">9</xref>]. Therefore, effective PEDV detection and antibody monitoring methods provide an important basis for the prevention and control of PED. Currently, PEDV detection methods include etiological and serological diagnosis, among which serological detection can be used for herd immunity status monitoring and evaluation of the protective effects post vaccination for a long period of time [<xref rid="B26-vetsci-12-00101" ref-type="bibr">26</xref>]. Normally, serology methods, including indirect immunofluorescence (IFA) assay, virus neutralization (VN) assay and traditional enzyme-linked immunosorbent assay (ELISA), need to culture infectious viruses using certain facilities. Therefore, the assays using recombinant proteins as antigens are easier to operate and standardize, which is more suitable for regular laboratory diagnosis. A Bac-to-Bac baculovirus expression system was applied previously to express a truncated PEDV S1 protein, and it established an indirect ELISA method for detecting PEDV IgA antibodies, which was used for the examination of herd immunity and the evaluation of antibody levels post vaccination [<xref rid="B34-vetsci-12-00101" ref-type="bibr">34</xref>].</p><p>The classic hemagglutination inhibition (HI) assay is the derivation of hemagglutination assay (HA) for serological analysis of erythrocyte-agglutinating viruses, such as influenza virus and Newcastle disease virus [<xref rid="B35-vetsci-12-00101" ref-type="bibr">35</xref>,<xref rid="B36-vetsci-12-00101" ref-type="bibr">36</xref>]. The essence of HA and HI is the multivalent display of viral antigens, which previously could only be achieved by using live or inactivated virus particles. Here in the present study, we designed a chimeric PEDV spike protein carrying a C-terminal Spy tag (S1<sup>0A</sup>-Spy), which forms isopeptide covalent bonds with the SpyCatcher protein fused to the N-terminal of the self-assembling trimeric aldolase (mi3) nanoparticle (NP). The polyhedral configuration of the generated virus-like particle, designated S1<sup>0A</sup>-NP, was confirmed with transmission electron microscopy (TEM) and dynamic light scattering (DLS). The HA assay showed that the S1<sup>0A</sup>-NPs had a decent hemagglutinating activity, with an HAU of 2048 at a concentration of 1&#x000b5;M. The &#x0201c;empty&#x0201d; NPs do not have an HA ability, indicating that the PEDV S1<sup>0A</sup> protein is key to erythrocyte agglutination. The following HI analysis showed the agglutination could be effectively inhibited through PEDV S1<sup>0A</sup>&#x02013;antibody interaction. Utilization of this approach allows the conduction of HA or HI assays without virus propagation, which collectively minimalizes the absolute biosafety requirements. Similar HI assays were also designed for Middle East respiratory syndrome coronavirus (MERS-CoV) and influenza virus (IAV), both of which have an HA ability [<xref rid="B32-vetsci-12-00101" ref-type="bibr">32</xref>,<xref rid="B33-vetsci-12-00101" ref-type="bibr">33</xref>]. The results described in these two studies suggest that the NP-based HI assay is highly akin to HI assays performed with virus particles and could be used to differentiate antibody responses between virus genotypes.</p><p>Notably, despite being vastly reactive to antibodies, those &#x0201c;virus mimics&#x0201d; are also antigenic as potential vaccine candidates. Recent advances have shown that the artificial virus-like particles (VLPs) based on a rational design of viral proteins can elicit rapid and effective immune responses in vivo post vaccination with VLPs or VLP-coding mRNAs [<xref rid="B37-vetsci-12-00101" ref-type="bibr">37</xref>,<xref rid="B38-vetsci-12-00101" ref-type="bibr">38</xref>,<xref rid="B39-vetsci-12-00101" ref-type="bibr">39</xref>]. Therefore, the scheme for antigen exhibition on NPs used in this study could also be considered for the future &#x0201c;plug in and display&#x0201d; design of vaccine candidates.</p><p>The S1 subunit of the S protein has the highest immunogenicity among coronaviral proteins [<xref rid="B40-vetsci-12-00101" ref-type="bibr">40</xref>]. In the case of PEDV, the S1<sup>B</sup> domain, also known as the collagenase equivalent (COE) domain, was first identified as the receptor-binding domain (RBD) and the main target of (neutralizing) antibodies [<xref rid="B41-vetsci-12-00101" ref-type="bibr">41</xref>,<xref rid="B42-vetsci-12-00101" ref-type="bibr">42</xref>]. Meanwhile, researchers had identified that the N-terminal 249 amino acid residues of the S1 subunit of GII PEDV, mainly comprising the S1<sup>0</sup> domain, promote virus entry through adhesion to sialic acid (SA) moieties [<xref rid="B6-vetsci-12-00101" ref-type="bibr">6</xref>]. It was then confirmed that the S1<sup>0</sup> domain is also a major target of neutralizing antibodies, which function through blocking the SA attachment [<xref rid="B24-vetsci-12-00101" ref-type="bibr">24</xref>]. Therefore, the antibodies detected by HI can intuitively reflect the level of S1<sup>0</sup>-targeting neutralizing antibodies. Recent epidemiological studies indicate that the S1<sup>0</sup> domain of PEDV strains circulating in China undergoes rapid evolution, which might be associated with changes in virulence [<xref rid="B43-vetsci-12-00101" ref-type="bibr">43</xref>]. Consequently, serological analysis of the coordinative antibody responses shall be implemented, where the HI assay could serve as a versatile tool.</p><p>In the present study, we stabilized the PEDV S1<sup>0</sup> by Fc-fused expression with the adjacent S1<sup>A</sup> and a C-terminal Spy tag, resulting in the chimeric protein S1<sup>0A</sup>-Spy. This protein elicited neutralizing antibodies when used as an immunogen, and the newly developed HI assay based on this protein could distinguish PEDV-negative and -positive serum samples. In the analysis of 253 clinical serum samples, the results obtained by the HI assay are highly consistent with VN, as shown by statistical analysis. No VN-positive sample was negative for HI, suggesting that the HI assay is specific in neutralizing antibody detection. Meanwhile, one-third of the HI-positive samples (18 out of 54) is negative in VN analysis. Considering the overall results, it is unlikely that those samples contain only PEDV S1<sup>0</sup> antibodies, but rather the VN assay is less sensitive than the HI, and the neutralizing antibody titers in those samples are below the detection limit. It is possible that with the rapid evolution of PEDV S1<sup>0</sup>, the dominant epitopes that elicit neutralizing immune responses had gradually shift from S1<sup>B</sup> to S1<sup>0</sup>, while future epitope mapping analysis will be implemented with newly emerging PEDV strains. Taken together, due to the high specificity and sensitivity, the newly developed HI assay could be used as an alternative or complementary serology method for VN, especially when a large number of samples need to be screened within a short period of time.</p></sec><sec sec-type="conclusions" id="sec5-vetsci-12-00101"><title>5. Conclusions</title><p>We successfully developed and validated an HI assay for detecting neutralizing antibody levels in porcine serum samples. The results indicated that the nanoparticle-based, virus-free HI assay had good specificity and sensitivity, and the obtained HI titers have good relevancy with the corresponding VN titers. With the advantages in efficiency and biosafety, the newly established HI assay will find future utility in PEDV serology, such as in the evaluation of herd immunity and monitoring of vaccine compliance.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-vetsci-12-00101"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at: <uri xlink:href="https://www.mdpi.com/article/10.3390/vetsci12020101/s1">https://www.mdpi.com/article/10.3390/vetsci12020101/s1</uri>, Figure S1: <xref rid="vetsci-12-00101-f001" ref-type="fig">Figure 1</xref>B. Affinity-purified Fc-tagged S1<sup>0A</sup>-Spy was identified by Western blot; Figure S2: <xref rid="vetsci-12-00101-f001" ref-type="fig">Figure 1</xref>D. Purified NPs were analyzed by SDS-PAGE; Figure S3: <xref rid="vetsci-12-00101-f002" ref-type="fig">Figure 2</xref>B. TEM image of S1<sup>0A</sup>-NPs was negatively stained; Figure S4: <xref rid="vetsci-12-00101-f002" ref-type="fig">Figure 2</xref>A. SpyCatcher-mi3 was incubated with S1<sup>0A</sup>-SpyTag at a 1.5,1 molar ratio at 25&#x000b0;C for 36 h, followed by analysis of S1<sup>0A</sup>-NP formation via reducing SDS-PAGE; Table S1: HI and VN titer of 54 positive samples detected by HI assay.</p><supplementary-material id="vetsci-12-00101-s001" position="float" content-type="local-data"><media xlink:href="vetsci-12-00101-s001.zip"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, S.Z. and Y.L.; Methodology, Y.L.; Software, F.L.; Validation, W.Q. and Z.H.; Formal Analysis, M.Z.; Investigation, W.L.; Resources, Q.Y.; Data Curation, Y.L.; Writing&#x02014;Original Draft Preparation, F.L.; Writing&#x02014;Review and Editing, W.L. and Y.L.; Visualization, S.Z.; Supervision, W.L. and Y.L.; Project Administration, S.Z.; Funding Acquisition, W.L. and Y.L. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>The procedures for the care and use of animals in this animal study were approved by the Ethics Committee of the Sichuan Agricultural University Institutional Animal Care and Use Committee and were performed according to animal ethics guidelines and approved protocols (approval code 20240327).</p></notes><notes><title>Informed Consent Statement</title><p>Informed consent was obtained from all subjects involved in the study.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>All data analyzed during this study are available from the corresponding author upon reasonable request.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-vetsci-12-00101"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wood</surname><given-names>E.N.</given-names></name>
</person-group><article-title>An apparently new syndrome of porcine epidemic diarrhoea</article-title><source>Vet. Rec.</source><year>1977</year><volume>100</volume><fpage>243</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1136/vr.100.12.243</pub-id><pub-id pub-id-type="pmid">888300</pub-id>
</element-citation></ref><ref id="B2-vetsci-12-00101"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>J.F.</given-names></name>
<name><surname>Liu</surname><given-names>X.Z.</given-names></name>
<name><surname>Shi</surname><given-names>D.</given-names></name>
<name><surname>Shi</surname><given-names>H.Y.</given-names></name>
<name><surname>Zhang</surname><given-names>X.</given-names></name>
<name><surname>Feng</surname><given-names>L.</given-names></name>
</person-group><article-title>Complete genome sequence of a porcine epidemic diarrhea virus variant</article-title><source>J. Virol.</source><year>2012</year><volume>86</volume><fpage>3408</fpage><pub-id pub-id-type="doi">10.1128/JVI.07150-11</pub-id><pub-id pub-id-type="pmid">22354946</pub-id>
</element-citation></ref><ref id="B3-vetsci-12-00101"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Morris</surname><given-names>D.R.</given-names></name>
<name><surname>Geballe</surname><given-names>A.P.</given-names></name>
</person-group><article-title>Upstream open reading frames as regulators of mRNA translation</article-title><source>Mol. Cell. Biol.</source><year>2020</year><volume>20</volume><fpage>8635</fpage><lpage>8642</lpage><pub-id pub-id-type="doi">10.1128/MCB.20.23.8635-8642.2000</pub-id></element-citation></ref><ref id="B4-vetsci-12-00101"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ji</surname><given-names>C.M.</given-names></name>
<name><surname>Wang</surname><given-names>B.</given-names></name>
<name><surname>Zhou</surname><given-names>J.Y.</given-names></name>
<name><surname>Huang</surname><given-names>Y.W.</given-names></name>
</person-group><article-title>Aminopeptidase-N-independent entry of porcine epidemic diarrhea virus into Vero or porcine small intestine epithelial cells</article-title><source>Virology</source><year>2018</year><volume>517</volume><fpage>16</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2018.02.019</pub-id><pub-id pub-id-type="pmid">29502803</pub-id>
</element-citation></ref><ref id="B5-vetsci-12-00101"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sternberg</surname><given-names>A.</given-names></name>
<name><surname>Naujokat</surname><given-names>C.</given-names></name>
</person-group><article-title>Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination</article-title><source>Life Sci.</source><year>2020</year><volume>257</volume><fpage>257</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2020.118056</pub-id><pub-id pub-id-type="pmid">32645344</pub-id>
</element-citation></ref><ref id="B6-vetsci-12-00101"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>W.T.</given-names></name>
<name><surname>Van Kuppeveld</surname><given-names>F.J.M.</given-names></name>
<name><surname>He</surname><given-names>Q.G.</given-names></name>
<name><surname>Rottier</surname><given-names>P.J.M.</given-names></name>
<name><surname>Bosch</surname><given-names>B.J.</given-names></name>
</person-group><article-title>Cellular entry of the porcine epidemic diarrhea virus</article-title><source>Virus Res.</source><year>2016</year><volume>226</volume><fpage>117</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1016/j.virusres.2016.05.031</pub-id><pub-id pub-id-type="pmid">27317167</pub-id>
</element-citation></ref><ref id="B7-vetsci-12-00101"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>Y.H.</given-names></name>
<name><surname>Chen</surname><given-names>Y.J.</given-names></name>
<name><surname>Yuan</surname><given-names>W.F.</given-names></name>
<name><surname>Peng</surname><given-names>Q.</given-names></name>
<name><surname>Zhang</surname><given-names>F.F.</given-names></name>
<name><surname>Ye</surname><given-names>Y.</given-names></name>
<name><surname>Huang</surname><given-names>D.Y.</given-names></name>
<name><surname>Ding</surname><given-names>Z.</given-names></name>
<name><surname>Lin</surname><given-names>L.H.</given-names></name>
<name><surname>He</surname><given-names>H.J.</given-names></name>
<etal/>
</person-group><article-title>Evaluation of Cross-Protection between G1a- and G2a-Genotype Porcine Epidemic Diarrhea Viruses in Suckling Piglets</article-title><source>Animals</source><year>2020</year><volume>10</volume><elocation-id>1674</elocation-id><pub-id pub-id-type="doi">10.3390/ani10091674</pub-id><pub-id pub-id-type="pmid">32957461</pub-id>
</element-citation></ref><ref id="B8-vetsci-12-00101"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pensaert</surname><given-names>M.B.</given-names></name>
<name><surname>De Bouck</surname><given-names>P.</given-names></name>
</person-group><article-title>A new coronavirus-like particle associated with diarrhea in swine</article-title><source>Adv. Virol.</source><year>1978</year><volume>58</volume><fpage>243</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1007/BF01317606</pub-id></element-citation></ref><ref id="B9-vetsci-12-00101"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>W.T.</given-names></name>
<name><surname>Li</surname><given-names>H.</given-names></name>
<name><surname>Liu</surname><given-names>Y.B.</given-names></name>
<name><surname>Pan</surname><given-names>Y.F.</given-names></name>
<name><surname>Deng</surname><given-names>F.</given-names></name>
<name><surname>Song</surname><given-names>Y.H.</given-names></name>
<name><surname>Tang</surname><given-names>X.B.</given-names></name>
<name><surname>He</surname><given-names>Q.G.</given-names></name>
</person-group><article-title>New Variants of Porcine Epidemic Diarrhea Virus, China, 2011</article-title><source>Emerg. Infect. Dis.</source><year>2012</year><volume>18</volume><fpage>1350</fpage><lpage>1353</lpage><pub-id pub-id-type="doi">10.3201/eid1803.120002</pub-id><pub-id pub-id-type="pmid">22840964</pub-id>
</element-citation></ref><ref id="B10-vetsci-12-00101"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sun</surname><given-names>R.Q.</given-names></name>
<name><surname>Cai</surname><given-names>R.J.</given-names></name>
<name><surname>Chen</surname><given-names>Y.Q.</given-names></name>
<name><surname>Liang</surname><given-names>P.S.</given-names></name>
<name><surname>Chen</surname><given-names>D.K.</given-names></name>
<name><surname>Song</surname><given-names>C.X.</given-names></name>
</person-group><article-title>Outbreak of porcine epidemic diarrhea in suckling piglets, China</article-title><source>Emerg. Infect. Dis.</source><year>2012</year><volume>18</volume><fpage>161</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.3201/eid1801.111259</pub-id><pub-id pub-id-type="pmid">22261231</pub-id>
</element-citation></ref><ref id="B11-vetsci-12-00101"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Oka</surname><given-names>T.</given-names></name>
<name><surname>Saif</surname><given-names>L.J.</given-names></name>
<name><surname>Marthaler</surname><given-names>D.</given-names></name>
<name><surname>Esseili</surname><given-names>M.A.</given-names></name>
<name><surname>Meulia</surname><given-names>T.</given-names></name>
<name><surname>Lin</surname><given-names>C.M.</given-names></name>
<name><surname>Vlasova</surname><given-names>A.N.</given-names></name>
<name><surname>Jung</surname><given-names>K.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>Q.</given-names></name>
</person-group><article-title>Cell culture isolation and sequence analysis of genetically diverse US porcine epidemic diarrhea virus strains including a novel strain with a large deletion in the spike gene</article-title><source>Vet. Microbiol.</source><year>2014</year><volume>173</volume><fpage>258</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1016/j.vetmic.2014.08.012</pub-id><pub-id pub-id-type="pmid">25217400</pub-id>
</element-citation></ref><ref id="B12-vetsci-12-00101"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Huang</surname><given-names>Y.W.</given-names></name>
<name><surname>Dickerman</surname><given-names>A.W.</given-names></name>
<name><surname>Pi&#x000f1;eyro</surname><given-names>P.</given-names></name>
<name><surname>Li</surname><given-names>L.</given-names></name>
<name><surname>Fang</surname><given-names>L.</given-names></name>
<name><surname>Kiehne</surname><given-names>R.</given-names></name>
<name><surname>Opriessnig</surname><given-names>T.</given-names></name>
<name><surname>Meng</surname><given-names>X.J.</given-names></name>
</person-group><article-title>Origin, evolution, and genotyping of emergent porcine epidemic diarrhea virus strains in the United States</article-title><source>mBio</source><year>2013</year><volume>4</volume><fpage>e00737-13</fpage><pub-id pub-id-type="doi">10.1128/mBio.00737-13</pub-id><pub-id pub-id-type="pmid">24129257</pub-id>
</element-citation></ref><ref id="B13-vetsci-12-00101"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Deng</surname><given-names>F.</given-names></name>
<name><surname>Ye</surname><given-names>G.</given-names></name>
<name><surname>Liu</surname><given-names>Q.Q.</given-names></name>
<name><surname>Navid</surname><given-names>M.T.</given-names></name>
<name><surname>Zhong</surname><given-names>X.l.</given-names></name>
<name><surname>Li</surname><given-names>Y.W.</given-names></name>
<name><surname>Wan</surname><given-names>C.Y.</given-names></name>
<name><surname>Xiao</surname><given-names>S.B.</given-names></name>
<name><surname>He</surname><given-names>Q.G.</given-names></name>
<name><surname>Fu</surname><given-names>Z.F.</given-names></name>
<etal/>
</person-group><article-title>Identification and Comparison of Receptor Binding Characteristics of the Spike Protein of Two Porcine Epidemic Diarrhea Virus Strains</article-title><source>Viruses</source><year>2016</year><volume>8</volume><elocation-id>55</elocation-id><pub-id pub-id-type="doi">10.3390/v8030055</pub-id><pub-id pub-id-type="pmid">26907329</pub-id>
</element-citation></ref><ref id="B14-vetsci-12-00101"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lin</surname><given-names>C.M.</given-names></name>
<name><surname>Saif</surname><given-names>L.J.</given-names></name>
<name><surname>Marthaler</surname><given-names>D.</given-names></name>
<name><surname>Wang</surname><given-names>Q.H.</given-names></name>
</person-group><article-title>Evolution, antigenicity and pathogenicity of global porcine epidemic diarrhea virus strains</article-title><source>Virus Res.</source><year>2016</year><volume>226</volume><fpage>20</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1016/j.virusres.2016.05.023</pub-id><pub-id pub-id-type="pmid">27288724</pub-id>
</element-citation></ref><ref id="B15-vetsci-12-00101"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lin</surname><given-names>H.X.</given-names></name>
<name><surname>Zhou</surname><given-names>H.</given-names></name>
<name><surname>Gao</surname><given-names>L.</given-names></name>
<name><surname>Li</surname><given-names>B.</given-names></name>
<name><surname>He</surname><given-names>K.W.</given-names></name>
<name><surname>Fan</surname><given-names>H.J.</given-names></name>
</person-group><article-title>Development and application of an indirect ELISA for the detection of antibodies to porcine epidemic diarrhea virus based on a recombinant spike protein</article-title><source>BMC Vet. Res.</source><year>2018</year><volume>14</volume><fpage>243</fpage><lpage>250</lpage><pub-id pub-id-type="doi">10.1186/s12917-018-1570-5</pub-id><pub-id pub-id-type="pmid">30126390</pub-id>
</element-citation></ref><ref id="B16-vetsci-12-00101"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Oh</surname><given-names>J.S.</given-names></name>
<name><surname>Lee</surname><given-names>K.W.</given-names></name>
<name><surname>Choi</surname><given-names>H.W.</given-names></name>
<name><surname>Lee</surname><given-names>C.</given-names></name>
</person-group><article-title>Immunogenicity and protective efficacy of recombinant S1 domain of the porcine epidemic diarrhea virus spike protein</article-title><source>Arch. Virol.</source><year>2014</year><volume>159</volume><fpage>2977</fpage><lpage>2987</lpage><pub-id pub-id-type="doi">10.1007/s00705-014-2163-7</pub-id><pub-id pub-id-type="pmid">25008896</pub-id>
</element-citation></ref><ref id="B17-vetsci-12-00101"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lee</surname><given-names>D.K.</given-names></name>
<name><surname>Park</surname><given-names>C.K.</given-names></name>
<name><surname>Kim</surname><given-names>S.H.</given-names></name>
<name><surname>Lee</surname><given-names>C.</given-names></name>
</person-group><article-title>Heterogeneity in spike protein genes of porcine epidemic diarrhea viruses isolated in Korea</article-title><source>Virus Res.</source><year>2010</year><volume>149</volume><fpage>175</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1016/j.virusres.2010.01.015</pub-id><pub-id pub-id-type="pmid">20132850</pub-id>
</element-citation></ref><ref id="B18-vetsci-12-00101"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kirchdoerfer</surname><given-names>R.N.</given-names></name>
<name><surname>Bhandari</surname><given-names>M.</given-names></name>
<name><surname>Martini</surname><given-names>O.</given-names></name>
<name><surname>Sewall</surname><given-names>L.M.</given-names></name>
<name><surname>Bangaru</surname><given-names>S.</given-names></name>
<name><surname>Yoon</surname><given-names>K.J.</given-names></name>
<name><surname>Ward</surname><given-names>A.B.</given-names></name>
</person-group><article-title>Structure and immune recognition of the porcine epidemic diarrhea virus spike protein</article-title><source>Structure</source><year>2021</year><volume>29</volume><fpage>385</fpage><lpage>392</lpage><pub-id pub-id-type="doi">10.1016/j.str.2020.12.003</pub-id><pub-id pub-id-type="pmid">33378641</pub-id>
</element-citation></ref><ref id="B19-vetsci-12-00101"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Luque</surname><given-names>D.</given-names></name>
<name><surname>Caston</surname><given-names>J.R.</given-names></name>
</person-group><article-title>Cryo-electron microscopy for the study of virus assembly</article-title><source>Nat. Chem. Biol.</source><year>2020</year><volume>16</volume><fpage>231</fpage><lpage>239</lpage><pub-id pub-id-type="doi">10.1038/s41589-020-0477-1</pub-id><pub-id pub-id-type="pmid">32080621</pub-id>
</element-citation></ref><ref id="B20-vetsci-12-00101"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Reguera</surname><given-names>J.</given-names></name>
<name><surname>Ordo&#x000f1;o</surname><given-names>D.</given-names></name>
<name><surname>Santiago</surname><given-names>C.</given-names></name>
<name><surname>Enjuanes</surname><given-names>L.</given-names></name>
<name><surname>Casasnovas</surname><given-names>J.M.</given-names></name>
</person-group><article-title>Antigenic modules in the N-terminal S1 region of the transmissible gastroenteritis virus spike protein</article-title><source>J. Gen. Virol.</source><year>2011</year><volume>92</volume><fpage>1117</fpage><lpage>1126</lpage><pub-id pub-id-type="doi">10.1099/vir.0.027607-0</pub-id><pub-id pub-id-type="pmid">21228126</pub-id>
</element-citation></ref><ref id="B21-vetsci-12-00101"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Raj</surname><given-names>V.S.</given-names></name>
<name><surname>Mou</surname><given-names>H.</given-names></name>
<name><surname>Smits</surname><given-names>S.L.</given-names></name>
<name><surname>Dekkers</surname><given-names>D.H.</given-names></name>
<name><surname>M&#x000fc;ller</surname><given-names>M.A.</given-names></name>
<name><surname>Dijkman</surname><given-names>R.</given-names></name>
<name><surname>Muth</surname><given-names>D.</given-names></name>
<name><surname>Demmers</surname><given-names>J.A.</given-names></name>
<name><surname>Zaki</surname><given-names>A.</given-names></name>
<name><surname>Fouchier</surname><given-names>R.A.</given-names></name>
<etal/>
</person-group><article-title>Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC</article-title><source>Nature</source><year>2013</year><volume>495</volume><fpage>251</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1038/nature12005</pub-id><pub-id pub-id-type="pmid">23486063</pub-id>
</element-citation></ref><ref id="B22-vetsci-12-00101"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mou</surname><given-names>H.</given-names></name>
<name><surname>Raj</surname><given-names>V.S.</given-names></name>
<name><surname>Van Kuppeveld</surname><given-names>F.J.</given-names></name>
<name><surname>Rottier</surname><given-names>P.J.</given-names></name>
<name><surname>Haagmans</surname><given-names>B.L.</given-names></name>
<name><surname>Bosch</surname><given-names>B.J.</given-names></name>
</person-group><article-title>The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies</article-title><source>J. Virol.</source><year>2013</year><volume>87</volume><fpage>9379</fpage><lpage>9383</lpage><pub-id pub-id-type="doi">10.1128/JVI.01277-13</pub-id><pub-id pub-id-type="pmid">23785207</pub-id>
</element-citation></ref><ref id="B23-vetsci-12-00101"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>C.Y.</given-names></name>
<name><surname>Li</surname><given-names>W.T.</given-names></name>
<name><surname>Drabek</surname><given-names>D.</given-names></name>
<name><surname>Okba</surname><given-names>N.M.A.</given-names></name>
<name><surname>van Haperen</surname><given-names>R.</given-names></name>
<name><surname>Osterhaus</surname><given-names>A.D.M.E.</given-names></name>
<name><surname>van Kuppeveld</surname><given-names>F.J.M.</given-names></name>
<name><surname>Haagmans</surname><given-names>B.L.</given-names></name>
<name><surname>Grosveld</surname><given-names>F.</given-names></name>
<name><surname>Bosch</surname><given-names>B.J.</given-names></name>
</person-group><article-title>A human monoclonal antibody blocking SARS-CoV-2 infection</article-title><source>Nat. Commun.</source><year>2020</year><volume>11</volume><fpage>2251</fpage><lpage>2256</lpage><pub-id pub-id-type="doi">10.1038/s41467-020-16256-y</pub-id><pub-id pub-id-type="pmid">32366817</pub-id>
</element-citation></ref><ref id="B24-vetsci-12-00101"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>C.H.</given-names></name>
<name><surname>Li</surname><given-names>W.T.</given-names></name>
<name><surname>Lucio De Esesarte</surname><given-names>E.</given-names></name>
<name><surname>Guo</surname><given-names>H.B.</given-names></name>
<name><surname>van den Elzen</surname><given-names>P.</given-names></name>
<name><surname>Aarts</surname><given-names>E.</given-names></name>
<name><surname>van den Born</surname><given-names>E.</given-names></name>
<name><surname>Rottier</surname><given-names>P.J.M.</given-names></name>
<name><surname>Bosch</surname><given-names>B.J.</given-names></name>
</person-group><article-title>Cell Attachment Domains of the Porcine Epidemic Diarrhea Virus Spike Protein Are Key Targets of Neutralizing Antibodies</article-title><source>J. Virol.</source><year>2017</year><volume>91</volume><fpage>e00273-17</fpage><pub-id pub-id-type="doi">10.1128/JVI.00273-17</pub-id><pub-id pub-id-type="pmid">28381581</pub-id>
</element-citation></ref><ref id="B25-vetsci-12-00101"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Olech</surname><given-names>M.</given-names></name>
</person-group><article-title>Current State of Molecular and Serological Methods for Detection of Porcine Epidemic Diarrhea Virus</article-title><source>Pathogens</source><year>2022</year><volume>11</volume><elocation-id>1074</elocation-id><pub-id pub-id-type="doi">10.3390/pathogens11101074</pub-id><pub-id pub-id-type="pmid">36297131</pub-id>
</element-citation></ref><ref id="B26-vetsci-12-00101"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Diel</surname><given-names>D.G.</given-names></name>
<name><surname>Lawson</surname><given-names>S.</given-names></name>
<name><surname>Okda</surname><given-names>F.</given-names></name>
<name><surname>Singrey</surname><given-names>A.</given-names></name>
<name><surname>Clement</surname><given-names>T.</given-names></name>
<name><surname>Fernandes</surname><given-names>M.H.V.</given-names></name>
<name><surname>Christopher-Hennings</surname><given-names>J.</given-names></name>
<name><surname>Nelson</surname><given-names>E.A.</given-names></name>
</person-group><article-title>Porcine epidemic diarrhea virus: An overview of current virological and serological diagnostic methods</article-title><source>Virus Res.</source><year>2016</year><volume>226</volume><fpage>60</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/j.virusres.2016.05.013</pub-id><pub-id pub-id-type="pmid">27189041</pub-id>
</element-citation></ref><ref id="B27-vetsci-12-00101"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ferrara</surname><given-names>G.</given-names></name>
<name><surname>D&#x02019;Anza</surname><given-names>E.</given-names></name>
<name><surname>Rossi</surname><given-names>A.</given-names></name>
<name><surname>Improda</surname><given-names>E.</given-names></name>
<name><surname>Iovane</surname><given-names>V.</given-names></name>
<name><surname>Pagnini</surname><given-names>U.</given-names></name>
<name><surname>Iovane</surname><given-names>G.</given-names></name>
<name><surname>Montagnaro</surname><given-names>S.</given-names></name>
</person-group><article-title>A Serological Investigation of Porcine Reproductive and Respiratory Syndrome and Three Coronaviruses in the Campania Region, Southern Italy</article-title><source>Viruses</source><year>2023</year><volume>15</volume><elocation-id>300</elocation-id><pub-id pub-id-type="doi">10.3390/v15020300</pub-id><pub-id pub-id-type="pmid">36851514</pub-id>
</element-citation></ref><ref id="B28-vetsci-12-00101"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Garc&#x000ed;a-Gonz&#x000e1;lez</surname><given-names>E.</given-names></name>
<name><surname>Cerrite&#x000f1;o-S&#x000e1;nchez</surname><given-names>J.L.</given-names></name>
<name><surname>Cuevas-Romero</surname><given-names>J.S.</given-names></name>
<name><surname>Garc&#x000ed;a-Cambr&#x000f3;n</surname><given-names>J.B.</given-names></name>
<name><surname>Casta&#x000f1;eda-Montes</surname><given-names>F.J.</given-names></name>
<name><surname>Villase&#x000f1;or-Ortega</surname><given-names>F.</given-names></name>
</person-group><article-title>Seroepidemiology Study of Porcine Epidemic Diarrhea Virus in Mexico by Indirect Enzyme-Linked Immunosorbent Assay Based on a Recombinant Fragment of N-Terminus Domain Spike Protein</article-title><source>Microorganisms</source><year>2023</year><volume>11</volume><elocation-id>1843</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms11071843</pub-id><pub-id pub-id-type="pmid">37513015</pub-id>
</element-citation></ref><ref id="B29-vetsci-12-00101"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Killian</surname><given-names>M.L.</given-names></name>
</person-group><article-title>Hemagglutination Assay for Influenza Virus</article-title><source>Methods Mol. Biol.</source><year>2020</year><volume>2123</volume><fpage>3</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">32170676</pub-id>
</element-citation></ref><ref id="B30-vetsci-12-00101"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Anderson</surname><given-names>T.C.</given-names></name>
<name><surname>Crawford</surname><given-names>P.C.</given-names></name>
<name><surname>Katz</surname><given-names>J.M.</given-names></name>
<name><surname>Dubovi</surname><given-names>E.J.</given-names></name>
<name><surname>Landolt</surname><given-names>G.</given-names></name>
<name><surname>Gibbs</surname><given-names>E.P.</given-names></name>
</person-group><article-title>Diagnostic performance of the canine Influenza A Virus subtype H3N8 hemagglutination inhibition assay</article-title><source>J. Vet. Diagn. Investig.</source><year>2012</year><volume>24</volume><fpage>499</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.1177/1040638712440992</pub-id><pub-id pub-id-type="pmid">22529116</pub-id>
</element-citation></ref><ref id="B31-vetsci-12-00101"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Morrison</surname><given-names>B.J.</given-names></name>
<name><surname>Martin</surname><given-names>N.J.</given-names></name>
<name><surname>Rehman</surname><given-names>T.</given-names></name>
<name><surname>Ewing</surname><given-names>D.</given-names></name>
<name><surname>Dewar</surname><given-names>R.L.</given-names></name>
<name><surname>Metcalf</surname><given-names>J.</given-names></name>
<name><surname>Sun</surname><given-names>P.</given-names></name>
<name><surname>Beigel</surname><given-names>J.</given-names></name>
<name><surname>Luke</surname><given-names>T.C.</given-names></name>
<name><surname>Raviprakash</surname><given-names>K.</given-names></name>
</person-group><article-title>Influence of sample collection tube method, anticoagulant-containing plasma versus serum, on influenza virus hemagglutination inhibition titer and microneutralization titer serological assays</article-title><source>BMC Health Serv. Res.</source><year>2018</year><volume>18</volume><fpage>651</fpage><lpage>661</lpage><pub-id pub-id-type="doi">10.1186/s12913-018-3465-3</pub-id><pub-id pub-id-type="pmid">30134892</pub-id>
</element-citation></ref><ref id="B32-vetsci-12-00101"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhao</surname><given-names>S.</given-names></name>
<name><surname>Schuurman</surname><given-names>N.</given-names></name>
<name><surname>Tieke</surname><given-names>M.</given-names></name>
<name><surname>Quist</surname><given-names>B.</given-names></name>
<name><surname>Zwinkels</surname><given-names>S.</given-names></name>
<name><surname>van Kuppeveld</surname><given-names>F.J.M.</given-names></name>
<name><surname>de Haan</surname><given-names>C.A.M.</given-names></name>
<name><surname>Egberink</surname><given-names>H.</given-names></name>
</person-group><article-title>Serological Screening of Influenza A Virus Antibodies in Cats and Dogs Indicates Frequent Infection with Different Subtypes</article-title><source>J. Clin. Microbiol.</source><year>2020</year><volume>58</volume><fpage>e01689-20</fpage><pub-id pub-id-type="doi">10.1128/JCM.01689-20</pub-id><pub-id pub-id-type="pmid">32878956</pub-id>
</element-citation></ref><ref id="B33-vetsci-12-00101"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Okba</surname><given-names>N.M.A.</given-names></name>
<name><surname>Widjaja</surname><given-names>I.</given-names></name>
<name><surname>Li</surname><given-names>W.T.</given-names></name>
<name><surname>GeurtsvanKessel</surname><given-names>C.H.</given-names></name>
<name><surname>Farag</surname><given-names>E.A.B.A.</given-names></name>
<name><surname>Al-Hajri</surname><given-names>M.</given-names></name>
<name><surname>Park</surname><given-names>W.B.</given-names></name>
<name><surname>Oh</surname><given-names>M.D.</given-names></name>
<name><surname>Reusken</surname><given-names>C.B.E.M.</given-names></name>
<name><surname>Koopmans</surname><given-names>M.P.G.</given-names></name>
<etal/>
</person-group><article-title>Serologic Detection of Middle East Respiratory Syndrome Coronavirus Functional Antibodies</article-title><source>Emerg. Infect. Dis.</source><year>2020</year><volume>26</volume><fpage>1024</fpage><lpage>1027</lpage><pub-id pub-id-type="doi">10.3201/eid2605.190921</pub-id><pub-id pub-id-type="pmid">32150528</pub-id>
</element-citation></ref><ref id="B34-vetsci-12-00101"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shan</surname><given-names>Y.</given-names></name>
<name><surname>Gao</surname><given-names>Q.</given-names></name>
<name><surname>Mao</surname><given-names>J.Y.</given-names></name>
<name><surname>Zheng</surname><given-names>J.Y.</given-names></name>
<name><surname>Xu</surname><given-names>X.H.</given-names></name>
<name><surname>Zhang</surname><given-names>C.N.</given-names></name>
<name><surname>Huang</surname><given-names>X.J.</given-names></name>
<name><surname>Xu</surname><given-names>J.D.</given-names></name>
<name><surname>Shi</surname><given-names>F.S.</given-names></name>
<name><surname>Yue</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Establishment of enzyme-linked immunosorbent assays based on recombinant S1 and its truncated proteins for detection of PEDV IgA antibody</article-title><source>BMC Vet. Res.</source><year>2022</year><volume>67</volume><fpage>2589</fpage><lpage>2601</lpage><pub-id pub-id-type="doi">10.1186/s12917-022-03262-z</pub-id><pub-id pub-id-type="pmid">35477403</pub-id>
</element-citation></ref><ref id="B35-vetsci-12-00101"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wu</surname><given-names>W.L.</given-names></name>
<name><surname>Chen</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>P.</given-names></name>
<name><surname>Song</surname><given-names>W.J.</given-names></name>
<name><surname>Lau</surname><given-names>S.Y.</given-names></name>
<name><surname>Rayner</surname><given-names>J.M.</given-names></name>
<name><surname>Smith</surname><given-names>G.J.</given-names></name>
<name><surname>Webster</surname><given-names>R.G.</given-names></name>
<name><surname>Peiris</surname><given-names>J.S.</given-names></name>
<name><surname>Lin</surname><given-names>T.W.</given-names></name>
<etal/>
</person-group><article-title>Antigenic Profile of Avian H5N1 Viruses in Asia from 2002 to 2007</article-title><source>J. Virol.</source><year>2008</year><volume>82</volume><fpage>1798</fpage><lpage>1807</lpage><pub-id pub-id-type="doi">10.1128/JVI.02256-07</pub-id><pub-id pub-id-type="pmid">18077726</pub-id>
</element-citation></ref><ref id="B36-vetsci-12-00101"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cattoli</surname><given-names>G.</given-names></name>
<name><surname>Susta</surname><given-names>L.</given-names></name>
<name><surname>Terregino</surname><given-names>C.</given-names></name>
<name><surname>Brown</surname><given-names>C.</given-names></name>
</person-group><article-title>Newcastle disease: A review of field recognition and current methods of laboratory detection</article-title><source>J. Vet. Diagn. Investig.</source><year>2011</year><volume>23</volume><fpage>637</fpage><lpage>656</lpage><pub-id pub-id-type="doi">10.1177/1040638711407887</pub-id><pub-id pub-id-type="pmid">21908305</pub-id>
</element-citation></ref><ref id="B37-vetsci-12-00101"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>M.H.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>Y.N.</given-names></name>
<name><surname>Li</surname><given-names>R.Q.</given-names></name>
<name><surname>Wang</surname><given-names>S.Q.</given-names></name>
<name><surname>Ding</surname><given-names>P.Y.</given-names></name>
<name><surname>Zhang</surname><given-names>G.P.</given-names></name>
</person-group><article-title>Accurate location of two conserved linear epitopes of PEDV utilizing monoclonal antibodies induced by S1 protein nanoparticles</article-title><source>Int. J. Biol. Macromol.</source><year>2023</year><volume>253</volume><fpage>127276</fpage><lpage>127287</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2023.127276</pub-id><pub-id pub-id-type="pmid">37804887</pub-id>
</element-citation></ref><ref id="B38-vetsci-12-00101"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hutchinson</surname><given-names>G.B.</given-names></name>
<name><surname>Abiona</surname><given-names>O.M.</given-names></name>
<name><surname>Ziwawo</surname><given-names>C.T.</given-names></name>
<name><surname>Werner</surname><given-names>A.P.</given-names></name>
<name><surname>Ellis</surname><given-names>D.</given-names></name>
<name><surname>Tsybovsky</surname><given-names>Y.</given-names></name>
<name><surname>Leist</surname><given-names>S.R.</given-names></name>
<name><surname>Palandjian</surname><given-names>C.</given-names></name>
<name><surname>West</surname><given-names>A.</given-names></name>
<name><surname>Fritch</surname><given-names>E.J.</given-names></name>
<etal/>
</person-group><article-title>Nanoparticle display of prefusion coronavirus spike elicits S1-focused cross-reactive antibody response against diverse coronavirus subgenera</article-title><source>Nat. Commun.</source><year>2023</year><volume>14</volume><fpage>6195</fpage><lpage>6205</lpage><pub-id pub-id-type="doi">10.1038/s41467-023-41661-4</pub-id><pub-id pub-id-type="pmid">37794071</pub-id>
</element-citation></ref><ref id="B39-vetsci-12-00101"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>J.</given-names></name>
<name><surname>Sun</surname><given-names>J.</given-names></name>
<name><surname>Ding</surname><given-names>X.</given-names></name>
<name><surname>Liu</surname><given-names>W.H.</given-names></name>
<name><surname>Wang</surname><given-names>Y.P.</given-names></name>
<name><surname>Wang</surname><given-names>Z.H.</given-names></name>
<name><surname>Peng</surname><given-names>H.Y.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Su</surname><given-names>W.H.</given-names></name>
<name><surname>Jiang</surname><given-names>C.I.</given-names></name>
</person-group><article-title>A nucleoside-modified mRNA vaccine forming rabies virus-like particle elicits strong cellular and humoral immune responses against rabies virus infection in mice</article-title><source>Emerg. Microbes Infect.</source><year>2024</year><volume>13</volume><fpage>2389115</fpage><lpage>2389131</lpage><pub-id pub-id-type="doi">10.1080/22221751.2024.2389115</pub-id><pub-id pub-id-type="pmid">39129566</pub-id>
</element-citation></ref><ref id="B40-vetsci-12-00101"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yang</surname><given-names>Y.L.</given-names></name>
<name><surname>Qin</surname><given-names>P.</given-names></name>
<name><surname>Wang</surname><given-names>B.</given-names></name>
<name><surname>Liu</surname><given-names>Y.</given-names></name>
<name><surname>Xu</surname><given-names>G.H.</given-names></name>
<name><surname>Peng</surname><given-names>L.</given-names></name>
<name><surname>Zhou</surname><given-names>J.</given-names></name>
<name><surname>Zhu</surname><given-names>S.J.</given-names></name>
<name><surname>Huang</surname><given-names>Y.W.</given-names></name>
</person-group><article-title>Broad Cross-Species Infection of Cultured Cells by Bat HKU2-Related Swine Acute Diarrhea Syndrome Coronavirus and Identification of Its Replication in Murine Dendritic Cells In Vivo Highlight Its Potential for Diverse Interspecies Transmission</article-title><source>J. Virol.</source><year>2019</year><volume>93</volume><fpage>e01448-19</fpage><pub-id pub-id-type="doi">10.1128/JVI.01448-19</pub-id><pub-id pub-id-type="pmid">31554686</pub-id>
</element-citation></ref><ref id="B41-vetsci-12-00101"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chang</surname><given-names>C.Y.</given-names></name>
<name><surname>Cheng</surname><given-names>I.C.</given-names></name>
<name><surname>Chang</surname><given-names>Y.C.</given-names></name>
<name><surname>Tsai</surname><given-names>P.S.</given-names></name>
<name><surname>Lai</surname><given-names>S.Y.</given-names></name>
<name><surname>Huang</surname><given-names>Y.L.</given-names></name>
<name><surname>Jeng</surname><given-names>C.R.</given-names></name>
<name><surname>Pang</surname><given-names>V.F.</given-names></name>
<name><surname>Chang</surname><given-names>H.W.</given-names></name>
</person-group><article-title>Identification of Neutralizing Monoclonal Antibodies Targeting Novel Conformational Epitopes of the Porcine Epidemic Diarrhoea Virus Spike Protein</article-title><source>Sci. Rep.</source><year>2019</year><volume>9</volume><fpage>2529</fpage><lpage>2539</lpage><pub-id pub-id-type="doi">10.1038/s41598-019-39844-5</pub-id><pub-id pub-id-type="pmid">30792462</pub-id>
</element-citation></ref><ref id="B42-vetsci-12-00101"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chang</surname><given-names>S.H.</given-names></name>
<name><surname>Bae</surname><given-names>J.L.</given-names></name>
<name><surname>Kang</surname><given-names>T.J.</given-names></name>
<name><surname>Kim</surname><given-names>J.</given-names></name>
<name><surname>Chung</surname><given-names>G.H.</given-names></name>
<name><surname>Lim</surname><given-names>C.W.</given-names></name>
<name><surname>Laude</surname><given-names>H.</given-names></name>
<name><surname>Yang</surname><given-names>M.S.</given-names></name>
<name><surname>Jang</surname><given-names>Y.S.</given-names></name>
</person-group><article-title>Identification of the Epitope Region Capable of Inducing Neutralizing Antibodies against the Porcine Epidemic Diarrhea Virus</article-title><source>Mol. Cells</source><year>2002</year><volume>14</volume><fpage>295</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.1016/S1016-8478(23)15106-5</pub-id><pub-id pub-id-type="pmid">12442904</pub-id>
</element-citation></ref><ref id="B43-vetsci-12-00101"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Su</surname><given-names>M.J.</given-names></name>
<name><surname>Li</surname><given-names>C.Q.</given-names></name>
<name><surname>Qi</surname><given-names>S.S.</given-names></name>
<name><surname>Yang</surname><given-names>D.</given-names></name>
<name><surname>Jiang</surname><given-names>N.</given-names></name>
<name><surname>Yin</surname><given-names>B.S.</given-names></name>
<name><surname>Guo</surname><given-names>D.H.</given-names></name>
<name><surname>Kong</surname><given-names>F.Z.</given-names></name>
<name><surname>Yuan</surname><given-names>D.W.</given-names></name>
<name><surname>Feng</surname><given-names>L.</given-names></name>
<etal/>
</person-group><article-title>A molecular epidemiological investigation of PEDV in China: Characterization of co-infection and genetic diversity of S1-based genes</article-title><source>Transbound. Emerg. Dis.</source><year>2019</year><volume>67</volume><fpage>1129</fpage><lpage>1140</lpage><pub-id pub-id-type="doi">10.1111/tbed.13439</pub-id><pub-id pub-id-type="pmid">31785090</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="vetsci-12-00101-f001"><label>Figure 1</label><caption><p>Construction and characterization of the recombinant S1<sup>0A</sup>-Spy protein and SpyCatcher-mi3 nanoparticles. (<bold>A</bold>): Schematic representation of the PEDV spike protein sequence (drawn to scale). S1 and S2 subunits of the 1380-aa-long PEDV spike protein are indicated, as well as the five domains of S1 and their respective boundaries: 0 (blue), A (orange), B (green) and CD (red). The S2 subunit is marked in dark gray. The position of the transmembrane domain (black bar) is indicated. Diagram of the S1 variant used in this study. (<bold>B</bold>): Affinity-purified Fc-tagged S1<sup>0A</sup>-Spy was identified by Western blot. M, protein marker, with numbers on the left side indicating molecular masses (in kilodaltons). (<bold>C</bold>): Cartoon presentation of the Plug-and-Display decoration of S1<sup>0A</sup>-nanoparticles (S1<sup>0A</sup>-NPs) by forming spontaneous isopeptide bonds between S1<sup>0A</sup>-Spy protein and SpyCatcher-mi3 nanoparticles. (<bold>D</bold>): Purified NPs were analyzed by SDS-PAGE. M, protein marker; numbers on the left are molecular masses (in kilodaltons).</p></caption><graphic xlink:href="vetsci-12-00101-g001" position="float"/></fig><fig position="float" id="vetsci-12-00101-f002"><label>Figure 2</label><caption><p>S1<sup>0A</sup>-Spy can be efficiently conjugated to SpyCatcher-mi3 NPs. (<bold>A</bold>): SpyCatcher-mi3 was incubated with S1<sup>0A</sup>-Spy at a 1.5:1 molar ratio at 25 &#x000b0;C for 36 h, followed by analysis of S1<sup>0A</sup>-NP formation via reducing SDS-PAGE. (<bold>B</bold>): TEM image of S1<sup>0A</sup>-NPs was negatively stained. Scale bar: 100 nm. (<bold>C</bold>,<bold>D</bold>): Particle sizes of SpyCatcher-mi3 NPs and S1<sup>0A</sup>-NPs were analyzed by DLS.</p></caption><graphic xlink:href="vetsci-12-00101-g002" position="float"/></fig><fig position="float" id="vetsci-12-00101-f003"><label>Figure 3</label><caption><p>NP-based HI assay has high specificity. (<bold>A</bold>) Hemagglutination of human erythrocytes using S1<sup>0A</sup>-NPs. S1<sup>0A</sup>-NPs or empty self-assembling mi3 nanoparticles were serially diluted and tested for the ability to agglutinate human RBCs. (<bold>B</bold>) Specificity of the HI assay for the detection of PEDV reference serum. Serum samples were serially diluted and tested for the ability to block S1<sup>0A</sup>-NP-induced hemagglutination of human RBCs.</p></caption><graphic xlink:href="vetsci-12-00101-g003" position="float"/></fig><fig position="float" id="vetsci-12-00101-f004"><label>Figure 4</label><caption><p>Venn diagram and ROC curve analysis of HI and VN detection results of pig serum samples. (<bold>A</bold>): Using Venn diagrams, the overlap between the number of positive samples in serum samples tested for HI and VN was shown. (<bold>B</bold>): The correlation of HI and VN to serum detection results was analyzed by the ROC curve.</p></caption><graphic xlink:href="vetsci-12-00101-g004" position="float"/></fig><table-wrap position="float" id="vetsci-12-00101-t001"><object-id pub-id-type="pii">vetsci-12-00101-t001_Table 1</object-id><label>Table 1</label><caption><p>Detection of anti-PEDV antibodies in pig serum samples.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin">Method</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">VN</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Total</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Positive Sample No.</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Negative Sample No.</th></tr></thead><tbody><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<bold>HI assay</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Positive sample no.</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">36</td><td align="center" valign="middle" rowspan="1" colspan="1">18</td><td align="center" valign="middle" rowspan="1" colspan="1">54</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Negative sample no.</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">199</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">199</td></tr><tr><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Total<break/><italic toggle="yes">Kappa</italic> value</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">36</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">217</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">253<break/>0.759</td></tr></tbody></table></table-wrap></floats-group></article>